Project Overview

Progression – or the steady worsening of disease and increase in disability – is a challenging reality faced by people affected by MS, and despite major advances in MS research, the mechanism of progression and the ways in which researchers and clinicians can track progression are still not fully understood. The CanProCo can have significant implications on how those living with MS manage and understand their illness from diagnoses and throughout the various stages of the disease. This study will look at progression from the biological, physical, and socioeconomic perspectives, and will meaningfully engage people living with MS so that their individual experiences are captured. Ultimately, the goal of the cohort is to connect biological findings with real world and clinical findings to create a comprehensive picture of progression in MS, with the hope that researchers will better understand the unpredictable nature of MS and find a cure.

Principal Investigator

Jiwon Oh , St. Michael’s Hospital

Team Members

Scott Patten, University of Calgary

Larry Lynd, University of British Columbia

Shannon Kolind, University of British Columbia

Anthony Traboulsee, University of British Columbia

Alexandre Prat, CHUM Research Centre, University of Montréal

Roger Tam, University of British Columbia

Penelope Smyth, University of Alberta

Partners and Donors

MS Society of Canada

Biogen Canada

Roche

Government of Alberta